Search Results - "Piccard, Martine"

Abstract OT1-1-01: LORELEI: A Phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early stage breast cancer by Saura, Cristina, de Azambuja, Evandro, Dubsky, Peter, Oliveira, Mafalda, Saini, Kamal S, Fes, Christian, Lin, Ray S, Wilson, Timothy R, Fredickson, Jill, Parmar, Hema, Hsu, Jerry Y, Piccard, Martine, Gnant, Michael, Baselga, Jose

“…Background: Taselisib (GDC-0032) is an orally bioavailable, potent, and selective inhibitor of Class I PI3-kinase (PI3K) alpha, gamma, and delta isoforms, with…”
Get full text

Chemotherapy for metastatic breast cancer-report of a European expert panel by Crown, John, Diéras, Véronique, Kaufmann, Manfred, von Minckwitz, Gunter, Kaye, Stan, Leonard, Robert, Marty, Michel, Misset, Jean-Louis, Osterwalder, Bruno, Piccart, Martine

“…The anthracyclines doxorubicin and epirubicin, and the taxanes paclitaxel and docetaxel, are effective chemotherapeutic agents for the first-line and…”
Get more information

Capecitabine efficacy is correlated with TYMP and RB expression in PDX established from triple-negative breast cancers by Marangoni, Elisabetta, Laurent, Cecile, Coussy, Florence, El Botty, Rania, Chateau-Joubert, Sophie, Servely, Jean-Luc, de Plater, Ludmilla, Assayag, Franck, Dahmani, Ahmed, Montaudon, Elodie, Nemati, Fariba, Fleury, Justine, Vacher, Sophie, Gentien, David, Rapinat, Audrey, Foidart, Pierre, Sounni, Nor Eddine, Noël, Agnès, Salomon, Anne, Lae, Marick, Decaudin, Didier, Roman-Roman, Sergio, Bieche, Ivan, Piccard, Martine, Reyal, Fabien

“…PURPOSE: triple-negative breast cancer (TNBC) patients with residual disease after neoadjuvant chemotherapy have a poor outcome. We developed patient-derived…”
Get full text